Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Revolutionizing Ovarian Cancer Market: Clinical Viewpoints, Pipeline Evaluation, & Market Access Services | Disease Landscape Insights

This image opens in the lightbox

News provided by

Disease Landscape Insights

21 Sep, 2023, 14:45 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, Sept. 21, 2023 /PRNewswire/ -- Ovarian cancer is one of the most commonly occurring ailments in women. One out of 78 women is at a risk of contracting this devastating disease. Ovarian cancer is characterized by the abnormal growth of cells in the ovaries. Its primary symptoms are abdominal pain, weight loss/gain, pelvic area discomfort, and bloating, among others. 


With an alarming rise in the number of Ovarian Cancer cases, healthcare experts worldwide are making efforts to develop effective diagnostic and treatment solutions for the same. But navigating through this path can be quite time consuming and challenging for the players. DLI's healthcare consulting services can transform the ovarian cancer care landscape by empowering players with deep dive understanding about this disease while simplifying complexed activities like clinical trial management and treatment gap identification.

Disease Overview: Ovarian Cancer- A global Concern-

Ovarian cancer accounts for the 5th highest cancer mortality rates across the globe. This statistics is indeed a matter of concern for health experts and national governments. This disease can affect women irrespective of their age or backgrounds. Ovarian cancer predominantly affects the reproductive organs of women including fallopian tubes and ultimately spreads to other organs if not treated or diagnosed in time. It leads to the formation of functional ovarian cyst that turn cancerous if not detected before it gets too late.  According to reliable sources, the United States alone has around 236,511 ovarian cancer patients and the numbers are projected to soar in the coming years.

Price and Market Access

Delving into the Symptoms of this ailment-

Ovarian cancer is often termed as a silent killer since it manifests mild symptoms in its initial stage. Some of its symptoms are similar to certain curable diseases, making its detection a significant challenge for oncologists. Common ovarian cancer symptoms of this ailment include persistent abdominal bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, frequent urination, changes in bowel habits, such as constipation or diarrhoea, unexplained weight loss, and fatigue. These symptoms are also seen in various non-cancerous diseases.

Health experts suggest that if women experience such symptoms persistently, they should opt for ovarian cancer screening. Early diagnosis can be a boon to patients since it paves the way for immediate treatment, thereby the reducing the risk of severity and mortality.

Ovarian Cancer Diagnosis- A Complexed Journey-

The diagnostic process of this malignancy can be quite complexed due to the absence of definitive symptoms. It typically involves a combination of different tests and physical examinations which are elaborated below-

Physical Examinations- The first step towards ovarian cancer diagnosis is a pelvic examination. In this process, the medical professional generally palpates the ovaries and surrounding areas for any abnormalities or signs of tumors.

Imaging Tests- CT scan, MRI, and ultrasound tests are generally conducted to detect any abnormalities or signs of tumors in the ovaries and surrounding tissues.

Biopsy- A tissue sample from ovaries or nearly tissues is removed and examined under a microscope in order to determine the presence of cancer cells.

Learn More About the FDA NDA & BLA Approval (NME) Drugs for Ovarian Cancer Disease @

https://www.diseaselandscape.com/requestsample/postid/78

Apart from the aforementioned techniques, historical evaluation and genetic testing are also conducted to detect this devastating ailment. Disease Landscape Insights Healthcare Consulting Services has been assisting players in enhancing their ovarian cancer diagnostic services and portfolio. Players can leverage DLI's deep dive expertise and gain strategic guidance to understand the dynamic landscape of this malignancy. Through data driven recommendations, epidemiology study, and commercial strategy analysis provided by this healthcare consultant, players can easily make informed business decisions.

Unlocking Ovarian Cancer Treatment Solutions-

With rigorous R&D activities in the field, numerous treatment solutions aimed a treating  this dreadful ailment have been developed. The treatment generally depends on the stage of cancer, symptoms, age and the overall health of the patient. Some of the most effective treatment methods are-

Chemotherapy:

It has emerged as one of the most commonly adopted cancer treatment technique. Here, certain drugs are used to destroy cancer cells and stall their growth.

Surgery:

Ovarian cancer debulking surgery, lyph node dissection, and fertility sparing surgery are some of the invasive procedures recommended during the course of treatment.

Discover More About Pricing and Reimbursement, Epidemiology Study, and Healthcare @

https://www.diseaselandscape.com/downloadsample/postid/78 

Immunotherapy:

With extensive advancements in the oncology care vertical, various researchers have discovered that the body's immune system can play an indispensable role in fighting cancer. In immunotherapy, the immune system is boosted with the help of drugs and medical entities, enhancing its capability to destroy cancer cells.

PARP Inhibitors:

Ovarian cancer can also be caused as a result of genetic defects. In such cases, PARP inhibitors have shown promising results. Patients with genetic mutations like BRCA1 or BRCA2 are recommended PARP inhibitors, especially in cases of cancer relapse.

Disease Landscape Insights Healthcare Consulting Services has been empowering healthcare organizations to solidify their ovarian cancer treatment portfolio. Its specialized consulting services covers critical areas such as regulatory compliance, drug development, and market access strategies. By facilitating rigorous epidemiological studies and identifying treatment gaps, they help clients develop targeted therapies that address unmet medical needs effectively. Through product portfolio analysis and product pipeline analysis, they guide the expansion of treatment options, ensuring a comprehensive approach to ovarian cancer care. Their expertise in clinical trial feasibility analysis and management streamlines the research process, while their insights into disease burden and commercial strategy analysis contribute to more informed and successful treatment strategies. Disease Landscape Insights Healthcare Consulting Services is instrumental in strengthening ovarian cancer treatment offerings, ultimately benefiting both healthcare providers and the patients they serve.

Unlock the Benefits Today! Get Started Now and Elevate Your Experience @

https://www.diseaselandscape.com/checkout?report_id=78

Future of Ovarian Cancer Care with DLI-

In the dynamic landscape of ovarian cancer care, Disease Landscape Insights (DLI) Healthcare Consulting Services has been a forefront, offering crucial pharma consulting services and drug launch strategies. These services are expediting the development and launch of groundbreaking therapies in this vertical. DLI's expertise in disease insights and clinical trial assessment helps players to successfully embark on a journey from research to patient treatment. Its guidance in pricing and reimbursement further ensures equitable market access for these innovative solutions. As ovarian cancer care continues to advance, DLI's commitment to comprehensive disease insights and strategic support promises a future where effective treatments reach those who need them most.

Search more about  Oncology Diseases

Related Case Study:

Case Study: Launch of a Medical High Tech Innovation

Case Study: Creation of an Antibiotic

Case Study: Antiallergic Drug Discovery Process Using Emerging Technologies

Case Study: New Drug Application (NDA) Preparation and Submission

Case Study: API Price Trends

Partnering with Commercial Laboratories for Monkeypox Detection Solutions to Fuel Business Expansion

Radiation therapy for lung cancer is used.

Lupus Immunomodulating Medications

To Increase Productivity Through Cost-Effective R&D and Launch More Affordable Drugs

Locating a Hemophilia Treatment Provider that Can Be Accepted

Commercialization of a Pneumonia Diagnostic Tool

Case study on the Development of Innovative Medicine

Case Study: Software Application for Personalized Care with Data-Driven Insights

Case Study: Cancer Vaccine with Specific Antigens

Combination Trials for Lung Cancer Immunotherapy - Case Study

Using software to manage the supply chain and the inventory

Asset Scouting for Cystic Fibrosis: A Case Study

A Revolutionary Non-Invasive Glucose Monitoring Device Receives Regulatory Approval and Effective Commercialization

Investment in Pancreatic Cancer Chemotherapy

About Disease Landscape: 

Disease Landscape, a pioneering company specializing in Disease Intelligence, Pricing, and Market Access. Utilizing the power of data analytics, Disease Landscape Insights is dedicated to healthcare sector with invaluable, finely crafted insights and recommendations regarding global pricing and market access strategies. As a specialized firm, we are committed to delivering unparalleled insights into pricing and market access, custom-tailored to the healthcare and pharmaceutical industries. Our data-driven solutions and cutting-edge technology position us as your trustworthy partner, offering swift, adaptable, and evidence-based alternatives to traditional market access and pricing research methods.  

Our core competencies encompass Market Research Services, Consulting Services, Global Pricing and Market Access, Epidemiology Studies, as well as Product Portfolio and Pipeline Services. Our expertise lies in furnishing comprehensive data intelligence throughout every phase of drug and device research.  

Contact Us:  

Disease Landscape Insights LLP 
6th Floor, Sr No.207, Office A H 6070 Phase 1 
Solitaire Business Hub, Viman Nagar 
Pune, Maharashtra, 411014 
Email: ajay@diseaselandscape.com   
Email: vishal@diseaselandscape.com 
Blog: https://www.diseaselandscape.com/blogs  
Case Study: https://www.diseaselandscape.com/casestudies  
Pharma consulting Services 
Follow Us: LinkedIn | Twitter | Facebook

Logo: https://mma.prnewswire.com/media/2217060/Disease_Landscape_Insights_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.